And

are now a part of the new and improved

Advertisement

Topic: Rosacea

Thumbnail for jhtapeki
Play Button

Toxin Progress

Series: Cosmetic Surgery Forum 2018 | December 5, 2018

With the evolution of existing neurotoxins and new agents on the horizon, there may soon be more treatment options than ever. Joel Schlessinger, MD, Founder and Chair of Cosmetic Surgery Forum, discusses the market and announces a change for CSF 2019!

Watch Video

News | December 19, 2018

National Rosacea Society: New Grants Available in 2019

The National Rosacea Society (NRS) has new grants available in 2019 to support research into potential causes and other key aspects of rosacea that may lead to improvements in its management, prevention, or potential cure. The deadline...

Read More
Clinical Focus | December 2018

Rosacea Update: New Findings on Risks and Impact

Understanding rosacea risk factors can allow for earlier, more effective treatment.
Joshua Zeichner, MD

Despite how common rosacea is, we have a poor understanding of its causes.1-4 Rosacea is a common, chronic skin condition characterized by flushing and blushing that may lead to persistent facial erythema as well as inflammatory papules and...

Read Article
Thumbnail for wmyemega
Play Button

2018 Therapeutics and Device Highlights

Series: DermWire TV | December 17, 2018

2018 saw new approvals and clearances for acne, impetigo, psoriasis, and skin cancer from Ortho Dermatologics, Sun Pharma, Cutanea, and more. Plus, updates for Restylane, new devices from BTL, Cutera, and others.

Watch Video

Advertisement

The Latest in Rosacea

Advertisement

View more